WebA hepatoma cell line, HuH-7 (JCRB0403), has been used extensively in various research fields and a number of studies using this line have been published continuously since it … WebThe ATCC Standards Development Organization has published a consensus standard (ASN-0002: Authentication of Human Cell Lines: Standardization of STR Profiling) to provide the research community with a globally-accepted methodology for assessing the identity of human cell lines.
Frontiers Identification of Characteristic Genomic Markers in …
WebJul 10, 2024 · Cancer Cell Lines with Mutant KRAS Genes. The heterogeneity of human cancers is a major obstacle to developing therapies. One way of dealing with that heterogeneity is to test large numbers of patient-derived cell lines for common vulnerabilities. For one such study , RAS Initiative researchers constructed GFP-labeled … WebApr 1, 2024 · Huh7 cells (hepatocellular carcinoma) were from the National Collection of Authenticated Cell Cultures (NCACC, Shanghai, China). HepG2 cells (hepatocellular carcinoma) were from the American Type Culture Collection (ATCC, Manassas, VA, USA). be:first ライブ 追加公演
HuT 78 - TIB-161 ATCC
WebApr 24, 2024 · The high permissiveness of the Huh7.5 and Huh7.5.1 cell lines is partly caused by mutational inactivation of retinoic-acid-inducible protein I (RIG-I), a cellular DExD/H box RNA helicase that senses viral RNA to mediate antiviral signaling, by an amino acid change at codon 55 from threonine to isoleucine (T55I) [ 16 ]. WebDec 4, 2024 · Currently, there are about 40 various hepatic tumor cell lines, but the most commonly used are HepaRG, Huh7, SK-Hep-1, Hep3B, and HepG2, obtained from various tumors (Figure 1). Among the cell culture mentioned above, the HepG2 cell line has gained popularity due to its wide range of applications in scientific research. WebMCF-7/S0.5 Human Breast Cancer Cell Line. Compare. Product No. Description. SDS. Pricing. SCC100. MCF-7/S0.5 is a tamoxifen-sensitive cell line established from the MCF-7 human breast cancer cell line by adaption to growth in low serum conditions. Expand. 卸町 日